Form 4: Zimmer Biomet Executive Sang Yi Reports Stock Transactions

Sang Yi, Group President, Asia Pacific at Zimmer Biomet Holdings, Inc., reports the vesting and disposal of restricted stock units.

Summary

• On February 20, 2025, Sang Yi, Group President, Asia Pacific at Zimmer Biomet Holdings, Inc., reported transactions involving Zimmer Biomet common stock and restricted stock units (RSUs).
• Yi disposed of 2,383 shares of common stock.
• The transaction also involved the vesting of 2,383 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Zimmer Biomet common stock.
• One-third of the RSUs vested on February 20, 2025, with the remainder vesting in two equal installments on February 20, 2026, and February 20, 2027.
• Following the reported transactions, Yi directly owns 4,764 derivative securities and 19,059 shares of common stock.

Sentiment

Score: 5

Explanation: This is a routine filing of stock transactions, so the sentiment is neutral.

Future Outlook

The remaining RSUs will vest in two equal installments on February 20, 2026, and February 20, 2027.

Industry Context

This Form 4 filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency into the executive's holdings and transactions in the company's stock.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it reflects an executive's compensation and investment decisions.

Key Dates